Alerts will be sent to your verified email
Verify Email
INDSWFTLTD
|
Ind-Swift
|
Makers Laboratories
|
Bharat Immunological
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.04 % | 0.31 % | -29.83 % |
|
5yr average Equity Multiplier
|
-0.95 | 2.36 | 3.08 |
|
5yr Average Asset Turnover Ratio
|
0.57 | 0.7 | 0.61 |
|
5yr Avg Net Profit Margin
|
-31.25 % | -0.21 % | -18.38 % |
|
Price to Book
|
0.0 | 1.3 | 1.21 |
|
P/E
|
0.32 | 12.23 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-141.81 Days | 75.08 Days | 206.63 Days |
|
Inventory Days
|
64.0 Days | 107.1 Days | 125.06 Days |
|
Days Receivable
|
88.62 Days | 71.83 Days | 61.4 Days |
|
Days Payable
|
283.86 Days | 106.28 Days | 117.81 Days |
|
5yr Average Interest Coverage Ratio
|
-4.31 | 4.73 | -2.32 |
|
5yr Avg ROCE
|
-53.05 % | 6.35 % | -44.64 % |
|
5yr Avg Operating Profit Margin
|
1.75 % | 7.59 % | -18.7 % |
|
5 yr average Debt to Equity
|
-1.52 | 0.21 | 0.71 |
|
5yr CAGR Net Profit
|
n/a | n/a | 23.51 % |
|
5yr Average Return on Assets
|
-12.25 % | 0.25 % | -10.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.58 % | 61.27 % | 59.25 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ind-Swift
|
Makers Laboratories
|
Bharat Immunological
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|